Medix-Pharma is committed to revolutionizing Africa’s healthcare system by leveraging cutting-edge technology and innovative solutions. With a focus on improving healthcare access and quality, Medix-Pharma aims to meet the growing healthcare needs across the continent, ensuring that patients receive reliable and effective pharmaceutical products. Partnering with BRASSICA, a well-established healthcare enterprise from India, Medix-Pharma operates a state-of-the-art manufacturing facility that produces a wide range of pharmaceutical products, including sterile ophthalmic ointments, dermatological creams and lotions, disinfectants, and various hospital supplies.

Sterile Eye Ointments/Gels & External Pre-Filled Syringes

Medix-Pharma specializes in the production of sterile eye ointments, gels, and external pre-filled syringes, all manufactured in a controlled environment to guarantee the highest levels of efficacy and safety. These products are essential in treating a variety of ocular conditions, offering patients effective relief and care. The production process is carried out under stringent conditions to meet international standards, ensuring that every product delivered is of the highest quality.

Our sterile eye ointments and gels are designed to provide rapid relief, preventing infections and reducing inflammation in the eye. The pre-filled syringes, designed for external use, are carefully manufactured to ensure precision and ease of application. Medix-Pharma’s focus on sterile formulations and cutting-edge manufacturing techniques ensures that every product is not only effective but also safe for use in delicate areas such as the eyes.

Dermatological Products

As part of its comprehensive pharmaceutical offering, Medix-Pharma specializes in dermatological products, including creams and lotions. These products are formulated to treat a variety of skin conditions, ranging from dry skin and rashes to more complex dermatological disorders. Medix-Pharma’s manufacturing facility adheres to stringent Good Manufacturing Practice (GMP) standards, ensuring that all products are consistently produced to the highest quality.

Our dermatological creams and lotions are crafted using the finest ingredients, ensuring they are gentle yet effective for skin care. We focus on creating formulations that provide long-lasting relief, hydration, and protection, while minimizing the risk of irritation or adverse reactions. By leveraging advanced technology and expertise, Medix-Pharma offers reliable solutions for a wide range of skin conditions, improving the lives of individuals across Africa.

Liquid Oral Pharmaceuticals

Medix-Pharma also produces liquid oral pharmaceutical products, including suspensions and syrups. These formulations are designed for easy consumption and are particularly beneficial for pediatric and geriatric patients who may have difficulty swallowing tablets or capsules. Medix-Pharma’s commitment to excellence in the production of these liquid products ensures that patients receive accurate dosages and effective treatment.

The liquid oral products manufactured by Medix-Pharma are created to meet a wide range of therapeutic needs, from addressing common ailments such as coughs and colds to treating more complex conditions such as infections and gastrointestinal disorders. These formulations are produced in compliance with the highest international standards, ensuring their safety, stability, and effectiveness.

Our Manufacturing Facility

At the heart of Medix-Pharma’s operations is its advanced manufacturing facility, built according to the highest international standards. Our facility is designed to meet European Union (EU) norms, ensuring that every product manufactured adheres to the most stringent quality and safety regulations. This modern manufacturing site plays a pivotal role in our mission to deliver superior pharmaceutical products to the African market.

The facility is equipped with state-of-the-art technology that ensures precision, efficiency, and consistency in production. With the capacity to produce large volumes of ophthalmic ointments and other pharmaceutical products, the facility is able to meet the demands of the growing African healthcare market. Our production capacity currently includes the ability to produce 100,000 tubes of ophthalmic ointments per shift, with plans for further expansion to accommodate increasing demand.

In addition to its manufacturing capabilities, the facility also includes dedicated spaces for research and development, where we continue to innovate and improve our formulations. This commitment to research ensures that Medix-Pharma remains at the forefront of pharmaceutical advancements, delivering new and improved products that meet the evolving healthcare needs of Africa.

A Commitment to Africa’s Healthcare Future

Medix-Pharma’s partnership with BRASSICA brings together years of expertise and knowledge from one of the leading healthcare companies in India. This collaboration allows Medix-Pharma to leverage BRASSICA’s proven manufacturing processes, while tailoring products specifically for the African market. The partnership aims to provide high-quality pharmaceutical products that are not only affordable but also easily accessible to patients across Africa.

Medix-Pharma’s vision is to address the healthcare challenges faced by many African countries by providing essential medical supplies and pharmaceuticals. Our focus is on building a healthcare ecosystem that is both sustainable and innovative, ensuring that all patients, regardless of location, can access the medications and treatments they need to improve their health and quality of life.

As part of our expansion strategy, Medix-Pharma is also working closely with local healthcare providers, distributors, and government organizations to improve the availability and accessibility of our products. By strengthening local distribution networks, Medix-Pharma ensures that its products reach the communities and hospitals that need them the most.

A New Manufacturing Site: Expanding Capacity to Meet Demand

Medix-Pharma’s commitment to meeting the growing demand for high-quality pharmaceuticals in Africa is reflected in its recent investment in a new manufacturing site. This site, built in accordance with EU standards, expands our capacity to produce large volumes of sterile ophthalmic products, dermatological ointments, creams, and other essential healthcare supplies. The new facility will play a key role in supporting our mission to improve healthcare in Africa by ensuring that we can meet both current and future market demands.

As the demand for pharmaceutical products continues to rise in Africa, Medix-Pharma remains focused on increasing its production capacity and expanding its product portfolio. The new manufacturing site will allow us to scale up our operations to better serve the needs of the African population, ensuring that we can deliver high-quality, affordable healthcare solutions to more patients across the continent.

Conclusion

Medix-Pharma is dedicated to transforming Africa’s healthcare landscape through innovation, technology, and high-quality pharmaceutical products. With its state-of-the-art manufacturing facility, advanced production capabilities, and commitment to excellence, Medix-Pharma is well-positioned to play a leading role in the growth of Africa’s healthcare industry. By partnering with BRASSICA, Medix-Pharma combines local expertise with international standards to deliver products that meet the diverse healthcare needs of the African population. Through this collaboration and continued expansion, Medix-Pharma is contributing to the development of a healthier, more sustainable Africa.